Healthcare professionals are reminded of the risk of photosensitivity reactions associated with topical ketoprofen.
The European Medicines Agency Committee for Medicinal Products for Human Use has recently completed a review of the medicine’s safety and efficacy, and has concluded that further measures should be put in place to minimise the risk of adverse skin reactions.
patients should ensure that treated areas are protected from sunlight during the whole period of topical ketoprofen treatment and for 2 weeks after stopping treatment; they should also carefully wash their hands after every application
patients should stop treatment immediately if they develop any skin reaction after application of these medicines and seek their doctor’s advice
patients should be informed of the appropriate use of topical ketoprofen as outlined in the product information